Overview

Efficacy and Safety of SPD465 in Adults With ADHD

Status:
Completed
Trial end date:
2005-06-14
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and effectiveness of SPD465 compared to placebo (a capsule with no medication in it) in the treatment of ADHD. The study will also look at how SPD465 affects sleep and how the participants perceive their quality of life.
Phase:
Phase 3
Details
Lead Sponsor:
Shire
Treatments:
Adderall
Amphetamine
Dextroamphetamine